Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands - PubMed (original) (raw)
. 1997 Nov 15;159(10):4943-51.
Affiliations
- PMID: 9366420
Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands
A Dressel et al. J Immunol. 1997.
Abstract
Determination of immunodominant epitopes of MHC class I-restricted self-Ags and elucidation of TCR contact residues is of potential importance in providing a means of manipulating the immune response to self-Ags in human autoimmune diseases. A computer algorithm was used to examine the sequences of the two major encephalitogenic proteins of myelin, MBP and PLP, for HLA-A2 binding motifs. Thirty-eight peptides with HLA-A2.1 binding motifs were synthesized and their binding to HLA-A2.1 was measured. A panel of HLA-A2-restricted T cell clones directed against the PLPp80-88 epitope, which exceeded the binding affinity of the other myelin-peptides tested by at least one order of magnitude, was generated. Using a set of analogue peptides with single amino acid substitutions, we detected a distinct pattern of TCR contact residues for each clone. Surprisingly, modification of different presumed TCR contact residues generated superagonist peptides, which are defined as peptides with equal or lower MHC binding affinity to HLA-A2 that induce half-maximal effector responses at 100-fold lower concentrations than the original peptide. These agonist peptides could drive cytotoxic T cell clones to proliferate, secrete cytokines, and clonally expand at concentrations at which the native peptide induced only cytotoxic responses. The proliferation induced by the superagonist peptides gives additional evidence that the clonal expansion of CD8 T cell clones may in part be regulated on the level of Ag recognition by the TCR.
Similar articles
- Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S, Barzaga E, Zhu M, Soares N, Tsang KY, Schlom J. Zaremba S, et al. Cancer Res. 1997 Oct 15;57(20):4570-7. Cancer Res. 1997. PMID: 9377571 - Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP. Berthelot L, et al. Eur J Immunol. 2008 Jul;38(7):1889-99. doi: 10.1002/eji.200838023. Eur J Immunol. 2008. PMID: 18506883 - Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI, Khleif SN, Bergmann-Leitner ES, Kantor JA, Chung Y, Hamilton JM, Schlom J. Abrams SI, et al. Cell Immunol. 1997 Dec 15;182(2):137-51. doi: 10.1006/cimm.1997.1224. Cell Immunol. 1997. PMID: 9514698 Clinical Trial. - The structural basis of HLA-associated drug hypersensitivity syndromes.
Pompeu YA, Stewart JD, Mallal S, Phillips E, Peters B, Ostrov DA. Pompeu YA, et al. Immunol Rev. 2012 Nov;250(1):158-66. doi: 10.1111/j.1600-065X.2012.01163.x. Immunol Rev. 2012. PMID: 23046128 Review. - Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
Nishimura Y, Chen YZ, Kanai T, Yokomizo H, Matsuoka T, Matsushita S. Nishimura Y, et al. Intern Med. 1998 Oct;37(10):804-17. doi: 10.2169/internalmedicine.37.804. Intern Med. 1998. PMID: 9840700 Review.
Cited by
- Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.
Tangri S, Ishioka GY, Huang X, Sidney J, Southwood S, Fikes J, Sette A. Tangri S, et al. J Exp Med. 2001 Sep 17;194(6):833-46. doi: 10.1084/jem.194.6.833. J Exp Med. 2001. PMID: 11560998 Free PMC article. - Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.
Sasaki K, Bean A, Shah S, Schutten E, Huseby PG, Peters B, Shen ZT, Vanguri V, Liggitt D, Huseby ES. Sasaki K, et al. J Immunol. 2014 Apr 1;192(7):3029-42. doi: 10.4049/jimmunol.1302911. Epub 2014 Mar 3. J Immunol. 2014. PMID: 24591371 Free PMC article. - CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis.
Sinha S, Boyden AW, Itani FR, Crawford MP, Karandikar NJ. Sinha S, et al. Front Immunol. 2015 Dec 10;6:619. doi: 10.3389/fimmu.2015.00619. eCollection 2015. Front Immunol. 2015. PMID: 26697014 Free PMC article. Review. - A pain-mediated neural signal induces relapse in murine autoimmune encephalomyelitis, a multiple sclerosis model.
Arima Y, Kamimura D, Atsumi T, Harada M, Kawamoto T, Nishikawa N, Stofkova A, Ohki T, Higuchi K, Morimoto Y, Wieghofer P, Okada Y, Mori Y, Sakoda S, Saika S, Yoshioka Y, Komuro I, Yamashita T, Hirano T, Prinz M, Murakami M. Arima Y, et al. Elife. 2015 Aug 11;4:e08733. doi: 10.7554/eLife.08733. Elife. 2015. PMID: 26193120 Free PMC article. - Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency.
Frausto RF, Crocker SJ, Eam B, Whitmire JK, Whitton JL. Frausto RF, et al. J Neuroimmunol. 2007 Dec;192(1-2):124-33. doi: 10.1016/j.jneuroim.2007.09.024. Epub 2007 Oct 26. J Neuroimmunol. 2007. PMID: 17964666 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous